Suppr超能文献

囊性纤维化患者雾化吸入多黏菌素后出现支气管收缩。

Bronchoconstriction following nebulised colistin in cystic fibrosis.

作者信息

Cunningham S, Prasad A, Collyer L, Carr S, Lynn I B, Wallis C

机构信息

Portex Anaesthesia, Intensive Care and Respiratory Medicine, Great Ormond Street Hospital for Children, Great Ormond Street, London WC1N 3JH, UK.

出版信息

Arch Dis Child. 2001 May;84(5):432-3. doi: 10.1136/adc.84.5.432.

Abstract

Nebulised colistin is regularly used as antipseudomonal therapy in children with cystic fibrosis. We assessed bronchoconstriction in response to nebulised colistin in 58 children. Nebulised colistin significantly reduced FEV(1), MEF(25%), and SaO(2) for 15 minutes. In 20 children the reduction was greater than 10% from baseline FEV(1), and was still at that level in five at 30 minutes. Subjective assessment, baseline FEV(1), and serum IgE were unable to identify susceptible children. It is recommended that children receiving colistin should be carefully assessed for bronchoconstriction.

摘要

雾化多黏菌素常用于囊性纤维化患儿的抗假单胞菌治疗。我们评估了58名儿童雾化吸入多黏菌素后的支气管收缩情况。雾化多黏菌素使FEV(1)、MEF(25%)和SaO(2)在15分钟内显著降低。20名儿童的FEV(1)较基线下降超过10%,其中5名儿童在30分钟时仍处于该水平。主观评估、基线FEV(1)和血清IgE均无法识别易发生支气管收缩的儿童。建议对接受多黏菌素治疗的儿童进行支气管收缩情况的仔细评估。

相似文献

7
Inhaled tobramycin and bronchial hyperactivity in cystic fibrosis.吸入用妥布霉素与囊性纤维化中的支气管高反应性
Pediatr Pulmonol. 2000 May;29(5):366-70. doi: 10.1002/(sici)1099-0496(200005)29:5<366::aid-ppul5>3.0.co;2-l.

引用本文的文献

3
Colistin Resistance in Molecular Mechanisms and Epidemiology.黏菌素耐药性的分子机制与流行病学
Antibiotics (Basel). 2023 Mar 4;12(3):516. doi: 10.3390/antibiotics12030516.
4
Causes of polymyxin treatment failure and new derivatives to fill the gap.多粘菌素治疗失败的原因及填补空白的新衍生物。
J Antibiot (Tokyo). 2022 Nov;75(11):593-609. doi: 10.1038/s41429-022-00561-3. Epub 2022 Sep 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验